Global Icosapent Ethyl Drugs Market Growth 2026-2032
The global Icosapent Ethyl Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Icosapent ethyl drugs are a type of omega-3 fatty acid medication specifically formulated to lower triglycerides and reduce the risk of cardiovascular events in patients with high triglyceride levels. The active ingredient, icosapent ethyl, is a purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid found in fish oil. These drugs, such as Vascepa, work by reducing the liver's production of triglycerides and promoting their breakdown.
United States market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Icosapent Ethyl Drugs players cover Woodward Pharma, Amarin Pharmaceuticals, Apotex, Hikma, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Icosapent Ethyl Drugs Industry Forecast” looks at past sales and reviews total world Icosapent Ethyl Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Icosapent Ethyl Drugs sales for 2026 through 2032. With Icosapent Ethyl Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icosapent Ethyl Drugs industry.
This Insight Report provides a comprehensive analysis of the global Icosapent Ethyl Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icosapent Ethyl Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Icosapent Ethyl Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icosapent Ethyl Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icosapent Ethyl Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Icosapent Ethyl Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Icosapent Ethyl Drugs market?
What factors are driving Icosapent Ethyl Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icosapent Ethyl Drugs market opportunities vary by end market size?
How does Icosapent Ethyl Drugs break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Icosapent ethyl drugs are a type of omega-3 fatty acid medication specifically formulated to lower triglycerides and reduce the risk of cardiovascular events in patients with high triglyceride levels. The active ingredient, icosapent ethyl, is a purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid found in fish oil. These drugs, such as Vascepa, work by reducing the liver's production of triglycerides and promoting their breakdown.
United States market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Icosapent Ethyl Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Icosapent Ethyl Drugs players cover Woodward Pharma, Amarin Pharmaceuticals, Apotex, Hikma, Dr. Reddy's Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Icosapent Ethyl Drugs Industry Forecast” looks at past sales and reviews total world Icosapent Ethyl Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Icosapent Ethyl Drugs sales for 2026 through 2032. With Icosapent Ethyl Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icosapent Ethyl Drugs industry.
This Insight Report provides a comprehensive analysis of the global Icosapent Ethyl Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icosapent Ethyl Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Icosapent Ethyl Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icosapent Ethyl Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icosapent Ethyl Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Icosapent Ethyl Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single Drug
- Combination Drug
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Woodward Pharma
- Amarin Pharmaceuticals
- Apotex
- Hikma
- Dr. Reddy's Laboratories
- Teva
- Ascent Pharmaceuticals
- Zydus
- Strides Pharma
- PuraCap Pharmaceuticals
- Sun Pharma
- Mankind Pharma
- Amneal Pharmaceuticals
- GLW Pharma
- Sichuan Gowell Pharmaceutical
- Qilu Pharmaceutical
- Chengdu Suncadia Medicine
- Jiangsu Wangao Pharmaceutical
- Humanwell Puracap Pharmaceuticals
What is the 10-year outlook for the global Icosapent Ethyl Drugs market?
What factors are driving Icosapent Ethyl Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icosapent Ethyl Drugs market opportunities vary by end market size?
How does Icosapent Ethyl Drugs break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icosapent Ethyl Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Icosapent Ethyl Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Icosapent Ethyl Drugs by Country/Region, 2021, 2025 & 2032
2.2 Icosapent Ethyl Drugs Segment by Type
2.2.1 Single Drug
2.2.2 Combination Drug
2.2.3 Icosapent Ethyl Drugs Sales by Type
2.2.3.1 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Icosapent Ethyl Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Icosapent Ethyl Drugs Sale Price by Type (2021-2026)
2.3 Icosapent Ethyl Drugs Segment by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.3.4 Icosapent Ethyl Drugs Sales by Application
2.3.4.1 Global Icosapent Ethyl Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Icosapent Ethyl Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Icosapent Ethyl Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Icosapent Ethyl Drugs Breakdown Data by Company
3.1.1 Global Icosapent Ethyl Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Icosapent Ethyl Drugs Sales Market Share by Company (2021-2026)
3.2 Global Icosapent Ethyl Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Icosapent Ethyl Drugs Revenue by Company (2021-2026)
3.2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Icosapent Ethyl Drugs Sale Price by Company
3.4 Key Manufacturers Icosapent Ethyl Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icosapent Ethyl Drugs Product Location Distribution
3.4.2 Players Icosapent Ethyl Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICOSAPENT ETHYL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Icosapent Ethyl Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Icosapent Ethyl Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Icosapent Ethyl Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Icosapent Ethyl Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Icosapent Ethyl Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Icosapent Ethyl Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Icosapent Ethyl Drugs Sales Growth
4.4 APAC Icosapent Ethyl Drugs Sales Growth
4.5 Europe Icosapent Ethyl Drugs Sales Growth
4.6 Middle East & Africa Icosapent Ethyl Drugs Sales Growth
5 AMERICAS
5.1 Americas Icosapent Ethyl Drugs Sales by Country
5.1.1 Americas Icosapent Ethyl Drugs Sales by Country (2021-2026)
5.1.2 Americas Icosapent Ethyl Drugs Revenue by Country (2021-2026)
5.2 Americas Icosapent Ethyl Drugs Sales by Type (2021-2026)
5.3 Americas Icosapent Ethyl Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icosapent Ethyl Drugs Sales by Region
6.1.1 APAC Icosapent Ethyl Drugs Sales by Region (2021-2026)
6.1.2 APAC Icosapent Ethyl Drugs Revenue by Region (2021-2026)
6.2 APAC Icosapent Ethyl Drugs Sales by Type (2021-2026)
6.3 APAC Icosapent Ethyl Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icosapent Ethyl Drugs by Country
7.1.1 Europe Icosapent Ethyl Drugs Sales by Country (2021-2026)
7.1.2 Europe Icosapent Ethyl Drugs Revenue by Country (2021-2026)
7.2 Europe Icosapent Ethyl Drugs Sales by Type (2021-2026)
7.3 Europe Icosapent Ethyl Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icosapent Ethyl Drugs by Country
8.1.1 Middle East & Africa Icosapent Ethyl Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Icosapent Ethyl Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Icosapent Ethyl Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Icosapent Ethyl Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icosapent Ethyl Drugs
10.3 Manufacturing Process Analysis of Icosapent Ethyl Drugs
10.4 Industry Chain Structure of Icosapent Ethyl Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icosapent Ethyl Drugs Distributors
11.3 Icosapent Ethyl Drugs Customer
12 WORLD FORECAST REVIEW FOR ICOSAPENT ETHYL DRUGS BY GEOGRAPHIC REGION
12.1 Global Icosapent Ethyl Drugs Market Size Forecast by Region
12.1.1 Global Icosapent Ethyl Drugs Forecast by Region (2027-2032)
12.1.2 Global Icosapent Ethyl Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Icosapent Ethyl Drugs Forecast by Type (2027-2032)
12.7 Global Icosapent Ethyl Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Woodward Pharma
13.1.1 Woodward Pharma Company Information
13.1.2 Woodward Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.1.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Woodward Pharma Main Business Overview
13.1.5 Woodward Pharma Latest Developments
13.2 Amarin Pharmaceuticals
13.2.1 Amarin Pharmaceuticals Company Information
13.2.2 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.2.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Amarin Pharmaceuticals Main Business Overview
13.2.5 Amarin Pharmaceuticals Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Icosapent Ethyl Drugs Product Portfolios and Specifications
13.3.3 Apotex Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Hikma
13.4.1 Hikma Company Information
13.4.2 Hikma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.4.3 Hikma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Main Business Overview
13.4.5 Hikma Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Icosapent Ethyl Drugs Product Portfolios and Specifications
13.6.3 Teva Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Ascent Pharmaceuticals
13.7.1 Ascent Pharmaceuticals Company Information
13.7.2 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.7.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ascent Pharmaceuticals Main Business Overview
13.7.5 Ascent Pharmaceuticals Latest Developments
13.8 Zydus
13.8.1 Zydus Company Information
13.8.2 Zydus Icosapent Ethyl Drugs Product Portfolios and Specifications
13.8.3 Zydus Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zydus Main Business Overview
13.8.5 Zydus Latest Developments
13.9 Strides Pharma
13.9.1 Strides Pharma Company Information
13.9.2 Strides Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.9.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Strides Pharma Main Business Overview
13.9.5 Strides Pharma Latest Developments
13.10 PuraCap Pharmaceuticals
13.10.1 PuraCap Pharmaceuticals Company Information
13.10.2 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.10.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 PuraCap Pharmaceuticals Main Business Overview
13.10.5 PuraCap Pharmaceuticals Latest Developments
13.11 Sun Pharma
13.11.1 Sun Pharma Company Information
13.11.2 Sun Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.11.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sun Pharma Main Business Overview
13.11.5 Sun Pharma Latest Developments
13.12 Mankind Pharma
13.12.1 Mankind Pharma Company Information
13.12.2 Mankind Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mankind Pharma Main Business Overview
13.12.5 Mankind Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 GLW Pharma
13.14.1 GLW Pharma Company Information
13.14.2 GLW Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 GLW Pharma Main Business Overview
13.14.5 GLW Pharma Latest Developments
13.15 Sichuan Gowell Pharmaceutical
13.15.1 Sichuan Gowell Pharmaceutical Company Information
13.15.2 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.15.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sichuan Gowell Pharmaceutical Main Business Overview
13.15.5 Sichuan Gowell Pharmaceutical Latest Developments
13.16 Qilu Pharmaceutical
13.16.1 Qilu Pharmaceutical Company Information
13.16.2 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.16.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Qilu Pharmaceutical Main Business Overview
13.16.5 Qilu Pharmaceutical Latest Developments
13.17 Chengdu Suncadia Medicine
13.17.1 Chengdu Suncadia Medicine Company Information
13.17.2 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolios and Specifications
13.17.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Chengdu Suncadia Medicine Main Business Overview
13.17.5 Chengdu Suncadia Medicine Latest Developments
13.18 Jiangsu Wangao Pharmaceutical
13.18.1 Jiangsu Wangao Pharmaceutical Company Information
13.18.2 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.18.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiangsu Wangao Pharmaceutical Main Business Overview
13.18.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.19 Humanwell Puracap Pharmaceuticals
13.19.1 Humanwell Puracap Pharmaceuticals Company Information
13.19.2 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.19.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Humanwell Puracap Pharmaceuticals Main Business Overview
13.19.5 Humanwell Puracap Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icosapent Ethyl Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Icosapent Ethyl Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Icosapent Ethyl Drugs by Country/Region, 2021, 2025 & 2032
2.2 Icosapent Ethyl Drugs Segment by Type
2.2.1 Single Drug
2.2.2 Combination Drug
2.2.3 Icosapent Ethyl Drugs Sales by Type
2.2.3.1 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Icosapent Ethyl Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Icosapent Ethyl Drugs Sale Price by Type (2021-2026)
2.3 Icosapent Ethyl Drugs Segment by Application
2.3.1 Hospital Pharmacy
2.3.2 Retail Pharmacy
2.3.3 Online Pharmacy
2.3.4 Icosapent Ethyl Drugs Sales by Application
2.3.4.1 Global Icosapent Ethyl Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Icosapent Ethyl Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Icosapent Ethyl Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Icosapent Ethyl Drugs Breakdown Data by Company
3.1.1 Global Icosapent Ethyl Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Icosapent Ethyl Drugs Sales Market Share by Company (2021-2026)
3.2 Global Icosapent Ethyl Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Icosapent Ethyl Drugs Revenue by Company (2021-2026)
3.2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Icosapent Ethyl Drugs Sale Price by Company
3.4 Key Manufacturers Icosapent Ethyl Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icosapent Ethyl Drugs Product Location Distribution
3.4.2 Players Icosapent Ethyl Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICOSAPENT ETHYL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Icosapent Ethyl Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Icosapent Ethyl Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Icosapent Ethyl Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Icosapent Ethyl Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Icosapent Ethyl Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Icosapent Ethyl Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Icosapent Ethyl Drugs Sales Growth
4.4 APAC Icosapent Ethyl Drugs Sales Growth
4.5 Europe Icosapent Ethyl Drugs Sales Growth
4.6 Middle East & Africa Icosapent Ethyl Drugs Sales Growth
5 AMERICAS
5.1 Americas Icosapent Ethyl Drugs Sales by Country
5.1.1 Americas Icosapent Ethyl Drugs Sales by Country (2021-2026)
5.1.2 Americas Icosapent Ethyl Drugs Revenue by Country (2021-2026)
5.2 Americas Icosapent Ethyl Drugs Sales by Type (2021-2026)
5.3 Americas Icosapent Ethyl Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icosapent Ethyl Drugs Sales by Region
6.1.1 APAC Icosapent Ethyl Drugs Sales by Region (2021-2026)
6.1.2 APAC Icosapent Ethyl Drugs Revenue by Region (2021-2026)
6.2 APAC Icosapent Ethyl Drugs Sales by Type (2021-2026)
6.3 APAC Icosapent Ethyl Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icosapent Ethyl Drugs by Country
7.1.1 Europe Icosapent Ethyl Drugs Sales by Country (2021-2026)
7.1.2 Europe Icosapent Ethyl Drugs Revenue by Country (2021-2026)
7.2 Europe Icosapent Ethyl Drugs Sales by Type (2021-2026)
7.3 Europe Icosapent Ethyl Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icosapent Ethyl Drugs by Country
8.1.1 Middle East & Africa Icosapent Ethyl Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Icosapent Ethyl Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Icosapent Ethyl Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Icosapent Ethyl Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icosapent Ethyl Drugs
10.3 Manufacturing Process Analysis of Icosapent Ethyl Drugs
10.4 Industry Chain Structure of Icosapent Ethyl Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icosapent Ethyl Drugs Distributors
11.3 Icosapent Ethyl Drugs Customer
12 WORLD FORECAST REVIEW FOR ICOSAPENT ETHYL DRUGS BY GEOGRAPHIC REGION
12.1 Global Icosapent Ethyl Drugs Market Size Forecast by Region
12.1.1 Global Icosapent Ethyl Drugs Forecast by Region (2027-2032)
12.1.2 Global Icosapent Ethyl Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Icosapent Ethyl Drugs Forecast by Type (2027-2032)
12.7 Global Icosapent Ethyl Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Woodward Pharma
13.1.1 Woodward Pharma Company Information
13.1.2 Woodward Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.1.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Woodward Pharma Main Business Overview
13.1.5 Woodward Pharma Latest Developments
13.2 Amarin Pharmaceuticals
13.2.1 Amarin Pharmaceuticals Company Information
13.2.2 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.2.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Amarin Pharmaceuticals Main Business Overview
13.2.5 Amarin Pharmaceuticals Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Icosapent Ethyl Drugs Product Portfolios and Specifications
13.3.3 Apotex Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Hikma
13.4.1 Hikma Company Information
13.4.2 Hikma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.4.3 Hikma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Main Business Overview
13.4.5 Hikma Latest Developments
13.5 Dr. Reddy's Laboratories
13.5.1 Dr. Reddy's Laboratories Company Information
13.5.2 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolios and Specifications
13.5.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Dr. Reddy's Laboratories Main Business Overview
13.5.5 Dr. Reddy's Laboratories Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Icosapent Ethyl Drugs Product Portfolios and Specifications
13.6.3 Teva Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Ascent Pharmaceuticals
13.7.1 Ascent Pharmaceuticals Company Information
13.7.2 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.7.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Ascent Pharmaceuticals Main Business Overview
13.7.5 Ascent Pharmaceuticals Latest Developments
13.8 Zydus
13.8.1 Zydus Company Information
13.8.2 Zydus Icosapent Ethyl Drugs Product Portfolios and Specifications
13.8.3 Zydus Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zydus Main Business Overview
13.8.5 Zydus Latest Developments
13.9 Strides Pharma
13.9.1 Strides Pharma Company Information
13.9.2 Strides Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.9.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Strides Pharma Main Business Overview
13.9.5 Strides Pharma Latest Developments
13.10 PuraCap Pharmaceuticals
13.10.1 PuraCap Pharmaceuticals Company Information
13.10.2 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.10.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 PuraCap Pharmaceuticals Main Business Overview
13.10.5 PuraCap Pharmaceuticals Latest Developments
13.11 Sun Pharma
13.11.1 Sun Pharma Company Information
13.11.2 Sun Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.11.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sun Pharma Main Business Overview
13.11.5 Sun Pharma Latest Developments
13.12 Mankind Pharma
13.12.1 Mankind Pharma Company Information
13.12.2 Mankind Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Mankind Pharma Main Business Overview
13.12.5 Mankind Pharma Latest Developments
13.13 Amneal Pharmaceuticals
13.13.1 Amneal Pharmaceuticals Company Information
13.13.2 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.13.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Amneal Pharmaceuticals Main Business Overview
13.13.5 Amneal Pharmaceuticals Latest Developments
13.14 GLW Pharma
13.14.1 GLW Pharma Company Information
13.14.2 GLW Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
13.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 GLW Pharma Main Business Overview
13.14.5 GLW Pharma Latest Developments
13.15 Sichuan Gowell Pharmaceutical
13.15.1 Sichuan Gowell Pharmaceutical Company Information
13.15.2 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.15.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sichuan Gowell Pharmaceutical Main Business Overview
13.15.5 Sichuan Gowell Pharmaceutical Latest Developments
13.16 Qilu Pharmaceutical
13.16.1 Qilu Pharmaceutical Company Information
13.16.2 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.16.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Qilu Pharmaceutical Main Business Overview
13.16.5 Qilu Pharmaceutical Latest Developments
13.17 Chengdu Suncadia Medicine
13.17.1 Chengdu Suncadia Medicine Company Information
13.17.2 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolios and Specifications
13.17.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Chengdu Suncadia Medicine Main Business Overview
13.17.5 Chengdu Suncadia Medicine Latest Developments
13.18 Jiangsu Wangao Pharmaceutical
13.18.1 Jiangsu Wangao Pharmaceutical Company Information
13.18.2 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
13.18.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiangsu Wangao Pharmaceutical Main Business Overview
13.18.5 Jiangsu Wangao Pharmaceutical Latest Developments
13.19 Humanwell Puracap Pharmaceuticals
13.19.1 Humanwell Puracap Pharmaceuticals Company Information
13.19.2 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
13.19.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Humanwell Puracap Pharmaceuticals Main Business Overview
13.19.5 Humanwell Puracap Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Icosapent Ethyl Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Icosapent Ethyl Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Drug
Table 4. Major Players of Combination Drug
Table 5. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Icosapent Ethyl Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Icosapent Ethyl Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Icosapent Ethyl Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Icosapent Ethyl Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Icosapent Ethyl Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Icosapent Ethyl Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Icosapent Ethyl Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Icosapent Ethyl Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Icosapent Ethyl Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Icosapent Ethyl Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Icosapent Ethyl Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Icosapent Ethyl Drugs Producing Area Distribution and Sales Area
Table 21. Players Icosapent Ethyl Drugs Products Offered
Table 22. Icosapent Ethyl Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icosapent Ethyl Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Icosapent Ethyl Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Icosapent Ethyl Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Icosapent Ethyl Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Icosapent Ethyl Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Icosapent Ethyl Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Icosapent Ethyl Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Icosapent Ethyl Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Icosapent Ethyl Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Icosapent Ethyl Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Icosapent Ethyl Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Icosapent Ethyl Drugs
Table 52. Key Market Challenges & Risks of Icosapent Ethyl Drugs
Table 53. Key Industry Trends of Icosapent Ethyl Drugs
Table 54. Icosapent Ethyl Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icosapent Ethyl Drugs Distributors List
Table 57. Icosapent Ethyl Drugs Customer List
Table 58. Global Icosapent Ethyl Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Icosapent Ethyl Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Icosapent Ethyl Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Icosapent Ethyl Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Icosapent Ethyl Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Icosapent Ethyl Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Icosapent Ethyl Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Icosapent Ethyl Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Icosapent Ethyl Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Icosapent Ethyl Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Icosapent Ethyl Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Woodward Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Woodward Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 74. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Woodward Pharma Main Business
Table 76. Woodward Pharma Latest Developments
Table 77. Amarin Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 79. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Amarin Pharmaceuticals Main Business
Table 81. Amarin Pharmaceuticals Latest Developments
Table 82. Apotex Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Apotex Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 84. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Apotex Main Business
Table 86. Apotex Latest Developments
Table 87. Hikma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Hikma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 89. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Hikma Main Business
Table 91. Hikma Latest Developments
Table 92. Dr. Reddy's Laboratories Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 94. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Dr. Reddy's Laboratories Main Business
Table 96. Dr. Reddy's Laboratories Latest Developments
Table 97. Teva Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 99. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Ascent Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 104. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ascent Pharmaceuticals Main Business
Table 106. Ascent Pharmaceuticals Latest Developments
Table 107. Zydus Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Zydus Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 109. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Zydus Main Business
Table 111. Zydus Latest Developments
Table 112. Strides Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Strides Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 114. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Strides Pharma Main Business
Table 116. Strides Pharma Latest Developments
Table 117. PuraCap Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 119. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. PuraCap Pharmaceuticals Main Business
Table 121. PuraCap Pharmaceuticals Latest Developments
Table 122. Sun Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sun Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 124. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Sun Pharma Main Business
Table 126. Sun Pharma Latest Developments
Table 127. Mankind Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Mankind Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 129. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Mankind Pharma Main Business
Table 131. Mankind Pharma Latest Developments
Table 132. Amneal Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 134. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Amneal Pharmaceuticals Main Business
Table 136. Amneal Pharmaceuticals Latest Developments
Table 137. GLW Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. GLW Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 139. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. GLW Pharma Main Business
Table 141. GLW Pharma Latest Developments
Table 142. Sichuan Gowell Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 144. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Sichuan Gowell Pharmaceutical Main Business
Table 146. Sichuan Gowell Pharmaceutical Latest Developments
Table 147. Qilu Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 149. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Qilu Pharmaceutical Main Business
Table 151. Qilu Pharmaceutical Latest Developments
Table 152. Chengdu Suncadia Medicine Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 154. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Chengdu Suncadia Medicine Main Business
Table 156. Chengdu Suncadia Medicine Latest Developments
Table 157. Jiangsu Wangao Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 159. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Jiangsu Wangao Pharmaceutical Main Business
Table 161. Jiangsu Wangao Pharmaceutical Latest Developments
Table 162. Humanwell Puracap Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 164. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Humanwell Puracap Pharmaceuticals Main Business
Table 166. Humanwell Puracap Pharmaceuticals Latest Developments
Table 1. Icosapent Ethyl Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Icosapent Ethyl Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Drug
Table 4. Major Players of Combination Drug
Table 5. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Icosapent Ethyl Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Icosapent Ethyl Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Icosapent Ethyl Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Icosapent Ethyl Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Icosapent Ethyl Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Icosapent Ethyl Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Icosapent Ethyl Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Icosapent Ethyl Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Icosapent Ethyl Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Icosapent Ethyl Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Icosapent Ethyl Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Icosapent Ethyl Drugs Producing Area Distribution and Sales Area
Table 21. Players Icosapent Ethyl Drugs Products Offered
Table 22. Icosapent Ethyl Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icosapent Ethyl Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Icosapent Ethyl Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Icosapent Ethyl Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Icosapent Ethyl Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Icosapent Ethyl Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Icosapent Ethyl Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Icosapent Ethyl Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Icosapent Ethyl Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Icosapent Ethyl Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Icosapent Ethyl Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Icosapent Ethyl Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Icosapent Ethyl Drugs
Table 52. Key Market Challenges & Risks of Icosapent Ethyl Drugs
Table 53. Key Industry Trends of Icosapent Ethyl Drugs
Table 54. Icosapent Ethyl Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icosapent Ethyl Drugs Distributors List
Table 57. Icosapent Ethyl Drugs Customer List
Table 58. Global Icosapent Ethyl Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Icosapent Ethyl Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Icosapent Ethyl Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Icosapent Ethyl Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Icosapent Ethyl Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Icosapent Ethyl Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Icosapent Ethyl Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Icosapent Ethyl Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Icosapent Ethyl Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Icosapent Ethyl Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Icosapent Ethyl Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Icosapent Ethyl Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Woodward Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Woodward Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 74. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Woodward Pharma Main Business
Table 76. Woodward Pharma Latest Developments
Table 77. Amarin Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 79. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Amarin Pharmaceuticals Main Business
Table 81. Amarin Pharmaceuticals Latest Developments
Table 82. Apotex Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Apotex Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 84. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Apotex Main Business
Table 86. Apotex Latest Developments
Table 87. Hikma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Hikma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 89. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Hikma Main Business
Table 91. Hikma Latest Developments
Table 92. Dr. Reddy's Laboratories Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 94. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Dr. Reddy's Laboratories Main Business
Table 96. Dr. Reddy's Laboratories Latest Developments
Table 97. Teva Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 99. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Ascent Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 104. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Ascent Pharmaceuticals Main Business
Table 106. Ascent Pharmaceuticals Latest Developments
Table 107. Zydus Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Zydus Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 109. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Zydus Main Business
Table 111. Zydus Latest Developments
Table 112. Strides Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Strides Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 114. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Strides Pharma Main Business
Table 116. Strides Pharma Latest Developments
Table 117. PuraCap Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 119. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. PuraCap Pharmaceuticals Main Business
Table 121. PuraCap Pharmaceuticals Latest Developments
Table 122. Sun Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sun Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 124. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Sun Pharma Main Business
Table 126. Sun Pharma Latest Developments
Table 127. Mankind Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Mankind Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 129. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Mankind Pharma Main Business
Table 131. Mankind Pharma Latest Developments
Table 132. Amneal Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 134. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Amneal Pharmaceuticals Main Business
Table 136. Amneal Pharmaceuticals Latest Developments
Table 137. GLW Pharma Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. GLW Pharma Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 139. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. GLW Pharma Main Business
Table 141. GLW Pharma Latest Developments
Table 142. Sichuan Gowell Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 144. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Sichuan Gowell Pharmaceutical Main Business
Table 146. Sichuan Gowell Pharmaceutical Latest Developments
Table 147. Qilu Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 149. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Qilu Pharmaceutical Main Business
Table 151. Qilu Pharmaceutical Latest Developments
Table 152. Chengdu Suncadia Medicine Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 154. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Chengdu Suncadia Medicine Main Business
Table 156. Chengdu Suncadia Medicine Latest Developments
Table 157. Jiangsu Wangao Pharmaceutical Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 159. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Jiangsu Wangao Pharmaceutical Main Business
Table 161. Jiangsu Wangao Pharmaceutical Latest Developments
Table 162. Humanwell Puracap Pharmaceuticals Basic Information, Icosapent Ethyl Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolios and Specifications
Table 164. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Humanwell Puracap Pharmaceuticals Main Business
Table 166. Humanwell Puracap Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Icosapent Ethyl Drugs
Figure 2. Icosapent Ethyl Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icosapent Ethyl Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Icosapent Ethyl Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Icosapent Ethyl Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Icosapent Ethyl Drugs Sales Market Share by Country/Region (2025)
Figure 10. Icosapent Ethyl Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Drug
Figure 12. Product Picture of Combination Drug
Figure 13. Global Icosapent Ethyl Drugs Sales Market Share by Type in 2026
Figure 14. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Icosapent Ethyl Drugs Consumed in Hospital Pharmacy
Figure 16. Global Icosapent Ethyl Drugs Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 17. Icosapent Ethyl Drugs Consumed in Retail Pharmacy
Figure 18. Global Icosapent Ethyl Drugs Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 19. Icosapent Ethyl Drugs Consumed in Online Pharmacy
Figure 20. Global Icosapent Ethyl Drugs Market: Online Pharmacy (2021-2026) & (K Units)
Figure 21. Global Icosapent Ethyl Drugs Sale Market Share by Application (2025)
Figure 22. Global Icosapent Ethyl Drugs Revenue Market Share by Application in 2026
Figure 23. Icosapent Ethyl Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Icosapent Ethyl Drugs Sales Market Share by Company in 2026
Figure 25. Icosapent Ethyl Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Icosapent Ethyl Drugs Revenue Market Share by Company in 2026
Figure 27. Global Icosapent Ethyl Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Icosapent Ethyl Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Icosapent Ethyl Drugs Sales Market Share by Country in 2026
Figure 38. Americas Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Icosapent Ethyl Drugs Sales Market Share by Region in 2026
Figure 46. APAC Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Icosapent Ethyl Drugs Sales Market Share by Country in 2026
Figure 57. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Icosapent Ethyl Drugs in 2026
Figure 74. Manufacturing Process Analysis of Icosapent Ethyl Drugs
Figure 75. Industry Chain Structure of Icosapent Ethyl Drugs
Figure 76. Channels of Distribution
Figure 77. Global Icosapent Ethyl Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Icosapent Ethyl Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Icosapent Ethyl Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Icosapent Ethyl Drugs
Figure 2. Icosapent Ethyl Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icosapent Ethyl Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Icosapent Ethyl Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Icosapent Ethyl Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Icosapent Ethyl Drugs Sales Market Share by Country/Region (2025)
Figure 10. Icosapent Ethyl Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Drug
Figure 12. Product Picture of Combination Drug
Figure 13. Global Icosapent Ethyl Drugs Sales Market Share by Type in 2026
Figure 14. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Icosapent Ethyl Drugs Consumed in Hospital Pharmacy
Figure 16. Global Icosapent Ethyl Drugs Market: Hospital Pharmacy (2021-2026) & (K Units)
Figure 17. Icosapent Ethyl Drugs Consumed in Retail Pharmacy
Figure 18. Global Icosapent Ethyl Drugs Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 19. Icosapent Ethyl Drugs Consumed in Online Pharmacy
Figure 20. Global Icosapent Ethyl Drugs Market: Online Pharmacy (2021-2026) & (K Units)
Figure 21. Global Icosapent Ethyl Drugs Sale Market Share by Application (2025)
Figure 22. Global Icosapent Ethyl Drugs Revenue Market Share by Application in 2026
Figure 23. Icosapent Ethyl Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Icosapent Ethyl Drugs Sales Market Share by Company in 2026
Figure 25. Icosapent Ethyl Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Icosapent Ethyl Drugs Revenue Market Share by Company in 2026
Figure 27. Global Icosapent Ethyl Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Icosapent Ethyl Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Icosapent Ethyl Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Icosapent Ethyl Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Icosapent Ethyl Drugs Sales Market Share by Country in 2026
Figure 38. Americas Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Icosapent Ethyl Drugs Sales Market Share by Region in 2026
Figure 46. APAC Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Icosapent Ethyl Drugs Sales Market Share by Country in 2026
Figure 57. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Icosapent Ethyl Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Icosapent Ethyl Drugs in 2026
Figure 74. Manufacturing Process Analysis of Icosapent Ethyl Drugs
Figure 75. Industry Chain Structure of Icosapent Ethyl Drugs
Figure 76. Channels of Distribution
Figure 77. Global Icosapent Ethyl Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Icosapent Ethyl Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Icosapent Ethyl Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Icosapent Ethyl Drugs Revenue Market Share Forecast by Application (2027-2032)
